Philips gets FDA clearance for high-performance MR 7700 system

MR 7700 imaging system features an enhanced gradient system for unmatched performance and precision

0
13
Philips MR 7700
MR Multi Nuclei are now more accurate thanks to Philips MR 7700 (Image: Philips)

Royal Philips has announced it has received FDA 510(k) clearance for the company’s new MR 7700 3.0T MR system. This latest break-through MR innovation from Philips delivers performance and precision for both research and advanced clinical diagnostics, helping to address the Quadruple Aim.

 

The XP gradients of MR 7700 provide high accuracy to support a confident diagnosis for every patient with Philips’ highest quality diffusion imaging and advanced neuroscience, supporting improved patient care and lower costs. MR 7700 expands scanning capabilities with a fully integrated multi-nuclei imaging and spectroscopy solution to explore new clinical pathways, without sacrificing clinical imaging workflow or wide-bore patient comfort, to enhance the experience of both staff and patients.

 

Scientists and clinicians could now access the scanner without compromising workflow. Driven by the seamless integration of multi-nuclei capabilities, the new MR 7700 allows radiologists to image six different clinically relevant nuclei across all anatomies, offering the ability to increase diagnostic confidence and add important metabolic information to MR exams to help tackle complex research programs and improve clinical decision-making to help provide improved patient care.

 

Orchestrating decision-making at pivotal moments in the patient’s care path journey

With all imaging protocols easily accessible via the same intuitive user-friendly interface, MR 7700 contributes to highly efficient radiology workflows and first-time-right scans. Combining high quality imaging with operational efficiency, its XP gradient coils achieve up to 35% higher signal-to-noise ratios and up to 35% shorter scan times. It claims to deliver detailed high-resolution images needed to confidently identify and characterize lesions.

 

AI-driven technology helps boost neuroscience excellence

Clinicians can leverage the MR 7700’s ultra-high gradients and in-built artificial intelligence, such as its AI-driven touchless patient sensing and motion detection, to address the upswing in patient volumes already being experienced by many of today’s radiology departments. Researchers can also leverage the accuracy, power, and endurance of the MR 7700’s XP gradients to help facilitate demanding research programs to boost neuroscience excellence.

 

Connecting and integrating workflows to drive clinical and operational efficiency

MR 7700 leverages the automated technology of SmartWorkflow to guide and coach where required. In addition to conventional proton magnetic resonance imaging and spectroscopy, MR 7700 has in-built MR protocols to combine proton imaging with imaging based on sodium, phosphorus, carbon, fluorine, and xenon. This multi-nuclei capability makes MR 7700 suitable for enhanced anatomical and metabolic/functional imaging in areas such as neurology, pulmonology, and oncology to help deliver fast, and confident definitive decision-making.

 

Via the integration of a dual-tuned head coil, both multi-nuclei and conventional proton MR exams can be performed with the same coil and within the same user interface to help increase workflow efficiencies, while AI-assisted workflow solutions keep exams on schedule to help improve both patient and staff experience. Finally, with access to proactive remote monitoring, remote diagnostics and remote field support, more than 500 parameters of the MR 7700 are monitored from a distance to detect and resolve issues without impacting department operations.

LEAVE A REPLY

Please enter your comment!
Please enter your name here